Pyrrolopyrimidine compounds as inhibitors of CDK4/6

Details for Australian Patent Application No. 2011217286 (hide)

Owner Novartis AG

Inventors Brain, Christopher Thomas; Cho, Young Shin; Giraldes, John William; Lagu, Bharat; Levell, Julian; Luzzio, Michael; Perez, Lawrence Blas; Wang, Yaping; Yang, Fan

Agent Davies Collison Cave

Pub. Number AU-A-2011217286

PCT Pub. Number WO2011/101409

Priority 61/429,372 03.01.11 US; 61/429,997 05.01.11 US; 61/306,248 19.02.10 US

Filing date 17 February 2011

Wipo publication date 25 August 2011

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 Antineoplastic agents

C07B 59/00 Introduction of isotopes of elements into organic compounds

C07D 519/00 Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/101409 Priority application(s): WO2011/101409

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011217287-System and method for producing conveyor belts having a wire rope core

2011217281-Tubular wall assembly and gasification reactor